MCRB
Price
$1.12
Change
-$0.01 (-0.88%)
Updated
Nov 29, 6:59 PM EST
98 days until earnings call
VTYX
Price
$2.23
Change
-$0.07 (-3.04%)
Updated
Nov 29, 6:59 PM EST
113 days until earnings call
Ad is loading...

Analysis and predictions MCRB vs VTYX

Header iconMCRB vs VTYX Comparison
Open Charts MCRB vs VTYXBanner chart's image
Seres Therapeutics
Price$1.12
Change-$0.01 (-0.88%)
Volume$1.52M
CapitalizationN/A
Ventyx Biosciences
Price$2.23
Change-$0.07 (-3.04%)
Volume$1.46M
CapitalizationN/A
View a ticker or compare two or three
MCRB vs VTYX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
MCRB vs. VTYX commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Buy and VTYX is a Sell.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (MCRB: $1.13 vs. VTYX: $2.30)
Brand notoriety: MCRB and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 32% vs. VTYX: 90%
Market capitalization -- MCRB: $149.94M vs. VTYX: $139.35M
MCRB [@Biotechnology] is valued at $149.94M. VTYX’s [@Biotechnology] market capitalization is $139.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than MCRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 5 bullish, 2 bearish.
  • VTYX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, MCRB is a better buy in the short-term than VTYX.

Price Growth

MCRB (@Biotechnology) experienced а +8.13% price change this week, while VTYX (@Biotechnology) price change was -1.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.60%. For the same industry, the average monthly price growth was +37.65%, and the average quarterly price growth was +9.10%.

Reported Earning Dates

MCRB is expected to report earnings on Mar 06, 2024.

VTYX is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (+4.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MCRB with price predictions.
OPEN
A.I.dvisor published
a Summary for VTYX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MCRB($150M) has a higher market cap than VTYX($139M). MCRB YTD gains are higher at: -79.821 vs. VTYX (-92.986). MCRB has higher annual earnings (EBITDA): -124.01M vs. VTYX (-190.82M). VTYX has more cash in the bank: 301M vs. MCRB (170M). VTYX has less debt than MCRB: VTYX (12.3M) vs MCRB (212M). MCRB has higher revenues than VTYX: MCRB (127M) vs VTYX (0).
MCRBVTYXMCRB / VTYX
Capitalization150M139M108%
EBITDA-124.01M-190.82M65%
Gain YTD-79.821-92.98686%
P/E RatioN/AN/A-
Revenue127M0-
Total Cash170M301M56%
Total Debt212M12.3M1,724%
FUNDAMENTALS RATINGS
MCRB: Fundamental Ratings
MCRB
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MCRBVTYX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLIIX10.440.03
+0.29%
First Sentier Global Listed Infras I
CGRRX7.840.01
+0.13%
Calvert Global Real Estate R6
ABVAX16.24-0.06
-0.37%
AB Value A
FIKNX17.88-0.11
-0.61%
Fidelity Advisor® Small Cap Value Z
HGHSX38.04-0.27
-0.70%
Hartford Healthcare R4

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with AURA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-2.54%
AURA - VTYX
57%
Loosely correlated
-0.13%
AKRO - VTYX
52%
Loosely correlated
+2.61%
KROS - VTYX
43%
Loosely correlated
-1.89%
CHRS - VTYX
39%
Loosely correlated
+8.76%
RAPT - VTYX
38%
Loosely correlated
+3.11%
More